PARNAX LAB Financial Statement Analysis
|
||
The Revenues of PARNAX LAB have increased by 2.81% YoY .
The Earnings Per Share (EPS) of PARNAX LAB has decreased by -10.71 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
PARNAX LAB Last 5 Annual Financial Results
[BOM: 506128]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹168 Cr | ₹163 Cr | ₹90 Cr | ₹95 Cr | ₹109 Cr |
Expenses | ₹145 Cr | ₹140 Cr | ₹80 Cr | ₹89 Cr | ₹99 Cr |
Operating Profit (Excl OI) | ₹23 Cr | ₹23 Cr | ₹9.95 Cr | ₹6.43 Cr | ₹10 Cr |
Other Income | ₹0.77 Cr | ₹0.33 Cr | ₹0.21 Cr | ₹0.67 Cr | ₹2.11 Cr |
Interest | ₹4.95 Cr | ₹5.23 Cr | ₹5.08 Cr | ₹4.60 Cr | ₹3.89 Cr |
Depreciation | ₹6.53 Cr | ₹5.87 Cr | ₹5.16 Cr | ₹4.46 Cr | ₹3.82 Cr |
Profit Before Tax | ₹12 Cr | ₹12 Cr | ₹-0.08 Cr | ₹-1.97 Cr | ₹4.62 Cr |
Profit After Tax | ₹8.63 Cr | ₹8.26 Cr | ₹-0.36 Cr | ₹-2.92 Cr | ₹3.31 Cr |
Consolidated Net Profit | ₹8.62 Cr | ₹8.24 Cr | ₹-0.36 Cr | ₹-2.91 Cr | ₹3.30 Cr |
Earnings Per Share (Rs) | ₹7.50 | ₹8.40 | ₹-0.43 | ₹-3.43 | ₹3.88 |
PAT Margin (%) | 5.15 | 5.07 | -0.40 | -3.06 | 3.04 |
ROE(%) | 15.91 | 20.93 | -1.11 | -8.51 | 9.69 |
ROCE(%) | 15.20 | 17.34 | 5.83 | 3.27 | 11.59 |
Total Debt/Equity(x) | 0.82 | 1.41 | 1.71 | 1.54 | 1.17 |
Key Financials |
||
Market Cap | : | ₹ 131.6 Cr |
Revenue (TTM) | : | ₹ 183.3 Cr |
Net Profit(TTM) | : | ₹ 8.8 Cr |
EPS (TTM) | : | ₹ 7.7 |
P/E (TTM) | : | 14.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
PARNAX LAB | -0.6% | -17.7% | 64.2% |
SUN PHARMACEUTICAL INDUSTRIES | -0.9% | 0.9% | 62.6% |
CIPLA | 3.5% | 4.2% | 51.8% |
DR REDDYS LABORATORIES | -1% | -2.4% | 28.4% |
ZYDUS LIFESCIENCES | 12.2% | 18% | 103.8% |
DIVIS LABORATORIES | 0.8% | 5.6% | 19.3% |
MANKIND PHARMA | -6.1% | -11.9% | 54.1% |
TORRENT PHARMACEUTICALS | 2.9% | 6.2% | 66.2% |
LUPIN | 1.5% | 4.2% | 109.2% |
PARNAX LAB Revenues
[BOM: 506128]
Y-o-Y | 2.81 % |
5 Yr CAGR | 11.41 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹168 Cr | 2.81 | |
Mar2022 | ₹163 Cr | 81.03 | |
Mar2021 | ₹90 Cr | -5.51 | |
Mar2020 | ₹95 Cr | -12.38 | |
Mar2019 | ₹109 Cr | - |
PARNAX LAB Operating Profit
[BOM: 506128]
Y-o-Y | -0.19 % |
5 Yr CAGR | 22.46 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹23 Cr | -0.19 | |
Mar2022 | ₹23 Cr | 131.53 | |
Mar2021 | ₹9.95 Cr | 54.77 | |
Mar2020 | ₹6.43 Cr | -37.12 | |
Mar2019 | ₹10 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -2.97 % |
5 Yr CAGR | 9.89 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 13.71% | -2.97 | |
Mar2022 | 14.13% | 27.99 | |
Mar2021 | 11.04% | 63.80 | |
Mar2020 | 6.74% | -28.30 | |
Mar2019 | 9.4% | - |
PARNAX LAB Profit After Tax
[BOM: 506128]
Y-o-Y | 4.55 % |
5 Yr CAGR | 27.13 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹8.62 Cr | 4.55 | |
Mar2022 | ₹8.24 Cr | Positive | |
Mar2021 | ₹-0.36 Cr | Negative | |
Mar2020 | ₹-2.91 Cr | Negative | |
Mar2019 | ₹3.30 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 1.58 % |
5 Yr CAGR | 14.09 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 5.15 % | 1.58 | |
Mar2022 | 5.07 % | Positive | |
Mar2021 | -0.4 % | Negative | |
Mar2020 | -3.06 % | Negative | |
Mar2019 | 3.04 % | - |
PARNAX LAB Earnings Per Share (EPS)
[BOM: 506128]
Y-o-Y | -10.71 % |
5 Yr CAGR | 17.91 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹7.50 | -10.71 | |
Mar2022 | ₹8.40 | Positive | |
Mar2021 | ₹-0.43 | Negative | |
Mar2020 | ₹-3.43 | Negative | |
Mar2019 | ₹3.88 | - |
PARNAX LAB Return on Capital Employed (ROCE)
[BOM: 506128]
Y-o-Y | -12.34 % |
5 Yr CAGR | 7.01 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 15.2% | -12.34 | |
Mar2022 | 17.34% | 197.43 | |
Mar2021 | 5.83% | 78.29 | |
Mar2020 | 3.27% | -71.79 | |
Mar2019 | 11.59% | - |
PARNAX LAB Share Price vs Sensex
Current Share Price | : | ₹114.5 |
Current MarketCap | : | ₹ 131.6 Cr |
Updated EOD on | : | May 18,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PARNAX LAB | -0.6% |
-17.7% |
64.2% |
SENSEX | 1.7% |
1.5% |
18.7% |
PARNAX LAB related INDICES
You may also like the below Video Courses
FAQ about PARNAX LAB Financials
How the annual revenues of PARNAX LAB have changed ?
The Revenues of PARNAX LAB have increased by 2.81% YoY .
How the Earnings per Share (EPS) of PARNAX LAB have changed?
The Earnings Per Share (EPS) of PARNAX LAB has decreased by -10.71 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs